Melodi Health Secures $10.75M in Series A Funding
Melodi Health, a Minneapolis-based medical device company, has secured $10.75 million in Series A funding which saw participation from HM Venture Partners, Engage Venture Partners, Southeast Minnesota Capital Fund, and Three Bridges Private Capital.
Melodi Health plans to direct the new funds towards clinical activities and additional product development efforts that align with their mission of transforming reconstructive surgery for women.
At present, 1 in 4 breast reconstructions experience complications. With 157,000 women choosing breast reconstruction after mastectomy each year, this is a high number of women experiencing complications each year.
So far, Melodi Health has developed their Melodi Matrix™, a clinical stage soft tissue support device that elutes antibiotics and absorbs into the body. This delivers soft tissue support immediately after reconstruction.
The company also announced the launch of the “ARIA” investigational device exemption (IDE) trial, a multicenter, nationwide, randomized, controlled study evaluating the safety and efficacy of the Melodi Matrix™ to support an FDA Approval for an indication in breast reconstruction. The Melodi Matrix technology was licensed from Medtronic.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
